These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3089438)
1. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Goldman M; Liesnard C; Vanherweghem JL; Dolle N; Toussaint C; Sprecher S; Cogniaux J; Thiry L Br Med J (Clin Res Ed); 1986 Jul; 293(6540):161-2. PubMed ID: 3089438 [TBL] [Abstract][Full Text] [Related]
2. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552 [TBL] [Abstract][Full Text] [Related]
3. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation]. Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545 [TBL] [Abstract][Full Text] [Related]
4. HTLV-III antibodies in hemodialysis patients--a consequence of blood transfusions? Schaefer K; Asmus G; Hüfler M; von Herrath D Klin Wochenschr; 1986 Jul; 64(13):621-2. PubMed ID: 3018352 [TBL] [Abstract][Full Text] [Related]
5. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Baillod RA; Lui SF; Sweny P; Ross MG; Griffiths PD; Grundy J; Moorhead JF Br Med J (Clin Res Ed); 1986 Sep; 293(6550):819. PubMed ID: 3094672 [No Abstract] [Full Text] [Related]
6. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106 [TBL] [Abstract][Full Text] [Related]
7. HTLV-III antibodies in patients with kidney transplants or on haemodialysis. Neumayer HH; Wagner K; Kresse S Lancet; 1986 Mar; 1(8479):497. PubMed ID: 2869226 [No Abstract] [Full Text] [Related]
9. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
10. HTLV-III infection among health care workers. Association with needle-stick injuries. Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694 [TBL] [Abstract][Full Text] [Related]
11. HTLV-III/LAV infection in hemodialysis patients. Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178 [TBL] [Abstract][Full Text] [Related]
13. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians. Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173 [TBL] [Abstract][Full Text] [Related]
14. Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome. Halbert SP; Poiesz B; Friedman-Kien AE; Montagna R; Blattner WA; Anken M J Clin Microbiol; 1986 Feb; 23(2):212-6. PubMed ID: 3009530 [TBL] [Abstract][Full Text] [Related]
15. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. Perez G; Ortiz-Interian C; Lee H; de Medina M; Cerney M; Allain JP; Schiff E; Parks E; Parks W; Bourgoignie JJ Am J Kidney Dis; 1989 Jul; 14(1):39-43. PubMed ID: 2787117 [TBL] [Abstract][Full Text] [Related]
17. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological evidence that HTLV-III is the AIDS agent. Goedert JJ; Gallo RC Eur J Epidemiol; 1985 Sep; 1(3):155-9. PubMed ID: 2945735 [TBL] [Abstract][Full Text] [Related]
20. Detection of HTLV-III antibody in cerebrospinal fluid from patients with AIDS and pre-AIDS with the use of a commercial test system. Johnson JE; Zolla-Pazner S Am J Clin Pathol; 1987 Sep; 88(3):351-3. PubMed ID: 3477084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]